文献速递胸部肿瘤

国际肺癌研究协会肺癌分期项目: forthcoming(第九版)肺癌TNM分类中TNM分期组修订建议

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2024-03-04

国际肺癌研究协会收集并分析新数据库,以期为即将发布的第九版肺癌TNM分类提供依据。剔除后共纳入76,518例患者进行分析,其中临床分期58,193例、病理分期39,192例、最佳分期非小细胞肺癌62,611例。分析评估了新的N2亚分类(N2a、N2b)和M1c亚分类(M1c1、M1c2),并提出第九版TNM分期组修订建议,分析显示所提分期分类具有一致的排序、预后区分度和广泛通用性。

要点

  • T1N1、T1N2a和T3N2a分别归入IIA、IIB和IIIA期组。
  • T2aN2b和T2bN2b归入IIIB期组。
  • M1c1和M1c2仍归入IVB期组。

核心结论

  • 所提出的第九版TNM分期提高了解剖范围命名细粒度,随着治疗方式日益分化和复杂,这具有益处。
  • 分析显示所提出的第九版肺癌分期分类具有一致的排序、预后区分度和广泛通用性。

研究设计与样本

  • 国际肺癌研究协会收集并分析新数据库,以期为即将发布的第九版TNM分类提供依据。
  • 剔除后,从总共124,581例注册患者中有76,518例患者可进行分析:临床分期58,193例,病理分期39,192例,最佳分期非小细胞肺癌62,611例。
  • 生存分析中考虑了新的N2亚分类(N2a:单个同侧纵隔或隆突下淋巴结站受累;N2b:多个同侧纵隔淋巴结站受累,伴或不伴隆突下淋巴结站受累)和新的M1c亚分类(M1c1:一个器官系统内多个胸外转移;M1c2:多个器官系统内多个胸外转移)。
  • 使用多种分析评估了几种潜在的分期组,包括递归 partitioning、潜在组内同质性和组间区分度评估、生存差异的临床和统计学显著性、多变量回归以及通用性的广泛评估。

主要发现

  • T1N1、T1N2a和T3N2a亚组分别归入IIA、IIB和IIIA期组。
  • T2aN2b和T2bN2b亚组归入IIIB期组。
  • M1c1和M1c2仍归入IVB期组。

关键数值与推荐

  • T1N1归入IIA期组。
  • T1N2a归入IIB期组。
  • T3N2a归入IIIA期组。
  • T2aN2b和T2bN2b归入IIIB期组。
  • M1c1和M1c2仍归入IVB期组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The TNM classification of lung cancer is periodically revised. The International Association for the Study of Lung Cancer collected and analyzed a new database to inform the forthcoming ninth edition of the TNM classification. The results are herewith presented. METHODS: After exclusions, 76,518 patients from a total of 124,581 registered patients were available for analyses: 58,193 with clinical stage, 39,192 with pathologic stage, and 62,611 with best stage NSCLC. The proposed new N2 subcategories (N2a, involvement of single ipsilateral mediastinal or subcarinal nodal station, and N2b, involvement of multiple ipsilateral mediastinal nodal stations with or without involvement of the subcarinal nodal station) and the new M1c subcategories (M1c1, multiple extrathoracic metastases in one organ system, and M1c2, multiple extrathoracic metastases in multiple organ systems) were considered in the survival analyses. Several potential stage groupings were evaluated, using multiple analyses, including recursive partitioning, assessment of homogeneity within and discrimination between potential groups, clinical and statistical significance of survival differences, multivariable regression, and broad assessment of generalizability. RESULTS: T1N1, T1N2a, and T3N2a subgroups are assigned to IIA, IIB, and IIIA stage groups, respectively. T2aN2b and T2bN2b subgroups are assigned to IIIB. M1c1 and M1c2 remain in stage group IVB. Analyses reveal consistent ordering, discrimination of prognosis, and broad generalizability of the proposed ninth edition stage classification of lung cancer. CONCLUSIONS: The proposed stages for the ninth edition TNM improve the granularity of nomenclature about anatomic extent that has benefits as treatment approaches become increasingly differentiated and complex.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Rami-Porta R, Nishimura KK, Giroux DJ, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024. PMID: 38447919. doi:10.1016/j.jtho.2024.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。